Ladenburg Thalmann Downgrades Genetic Technologies (GENE) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts GENE Hot Sheet
Price: $0.77 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Ladenburg Thalmann downgraded Genetic Technologies (NASDAQ: GENE) from Buy to Sell with a price target of $1.60 (from $7.50).
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.18 yesterday.
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi downgrades Pershing Square to Sell with $45 target
- China Renaissance Downgrades Xiaomi Corp (1810:HK) (XIACF) to Sell
- Northland Downgrades Semtech Corp. (SMTC) to Market Perform
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
